Skip to main content
. 2022 Mar 3;18(1):2035573. doi: 10.1080/21645515.2022.2035573

Table 3.

The geometric mean concentration (GMC) of anti-RBD antibody after a single dose of the AZD1222 vaccine (months)

Time elapsed from the first dose of AZD1222 (month) Sample (N) GMC of anti-SARS-CoV-2 antibody (95%CI) (BAU/mL) GMR (95%CI)*
Baseline level 794 0.4  
1 238 20.14 (16.37, 24.77) reference
2 438 48.08 (42.76, 54.08) 2.72 (2.21–3.33)
3 479 65.01 (58.88,71.61) 3.33 (2.73–4.05)

*adjust with age, sex, underlying disease, GMR; geometric mean ratio, 95%CI; 95% confidence interval.